Next Quarterly Earnings
Wednesday, August 5, 2026
CW 32
Pre-Market
In 31 days
Ionis Pharmaceuticals is a leading biopharmaceutical company dedicated to discovering and developing innovative RNA-targeted therapeutics. The company's primary focus is on treating rare and devastating diseases, particularly neurological disorders, leveraging groundbreaking antisense technology. Ionis is revolutionizing drug discovery to provide new treatment options for patients globally, aiming to significantly improve their quality of life.